19 related articles for article (PubMed ID: 6864045)
1. Antitumor activities of seventeen alkylating agents against human mammary carcinoma (MS-1) in nude mice.
Inoue K; Fujimoto S; Ogawa M
Nagoya J Med Sci; 1981 Mar; 43(3-4):89-100. PubMed ID: 7278943
[No Abstract] [Full Text] [Related]
2. [Analysis of chemosensitivity against a human breast cancer xenograft (MX-1) with the subrenal capsule assay in BDF1 mice].
Inoue K; Wang Y; Tada A; Ueno K; Kojima K; Ogawa M
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1644-50. PubMed ID: 4026333
[TBL] [Abstract][Full Text] [Related]
3. [Transplantation of in vitro cultured human tumors to nude mice and their use as chemotherapeutic test models].
Naundorf B; Arnold W; Nissen E; Wildner GP
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):652-7. PubMed ID: 6172329
[No Abstract] [Full Text] [Related]
4. Tumor-inhibiting potential of ZK 112.993, a new progesterone antagonist, in hormone-sensitive, experimental rodent and human mammary tumors.
Schneider MR; Michna H; Nishino Y; Neef G; el Etreby MF
Anticancer Res; 1990; 10(3):683-7. PubMed ID: 2369083
[TBL] [Abstract][Full Text] [Related]
5. [Preclinical screening of chemotherapeutic and endocrine agents using human tumor xenografts--nude mouse system].
Kubota T; Ishibiki K; Abe O
Gan To Kagaku Ryoho; 1991 Jul; 18(9):1439-47. PubMed ID: 1854214
[TBL] [Abstract][Full Text] [Related]
6. [Correlation between antitumor effects against human mammary carcinoma (MX-1) in nude mice and clinical efficacy of human breast cancer in thirty-four antitumor agents].
Inoue K; Fujimoto S; Ogawa M
Nihon Gan Chiryo Gakkai Shi; 1983 Feb; 18(1):13-20. PubMed ID: 6864045
[No Abstract] [Full Text] [Related]
7. Patient-derived tumour xenografts for breast cancer drug discovery.
Cassidy JW; Batra AS; Greenwood W; Bruna A
Endocr Relat Cancer; 2016 Dec; 23(12):T259-T270. PubMed ID: 27702751
[TBL] [Abstract][Full Text] [Related]
8. Issues in experimental design and endpoint analysis in the study of experimental cytotoxic agents in vivo in breast cancer and other models.
Clarke R
Breast Cancer Res Treat; 1997; 46(2-3):255-78. PubMed ID: 9478280
[TBL] [Abstract][Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
